AstraZeneca admits in court that its COVID vaccine can cause rare blood clots
Facebook
Twitter
LinkedIn
WhatsApp
Summary: In a legal dispute, AstraZeneca admits that its COVID-19 vaccination, sold under brand names like Covishield, can cause serious side effects such as blood clots in rare situations.
AstraZeneca, the pharmaceutical company, has revealed that its commonly used COVID vaccination, Covishield, might cause rare side effects such as blood clots and low platelet counts.
Covishield was created by a British-Swedish company in partnership with Oxford University, UK, and is manufactured by the Serum Institute of India. It was widely used in over 150 nations, including Britain and India.
Some trials conducted during the pandemic revealed that the vaccine was 60 to 80 percent effective in guarding against the new coronavirus.
Through the court action, several families claimed that the side effects of the AstraZeneca vaccine had fatal repercussions.
The company's recognition highlights the possible risks connected to vaccination and is a turning point in the current legal dispute.
Jamie Scott filed the claim in April 2021 after suffering a permanent brain injury from the AstraZeneca vaccine.
While AstraZeneca has denied these allegations early on, it accepted for the first time in court records that the vaccination in rare cases causes TSS, or Thrombosis with Thrombocytopenia Syndrome, a condition that causes blood clots and a low blood platelet count in humans.
“It is known that the AZ vaccination has an extremely rare possibility of causing TTS.” According to the Telegraph, the company stated this in court documents in February.
Due to safety concerns, the AstraZeneca-Oxford vaccination is no longer available for administration in the UK. While independent studies have shown its success in treating the epidemic, the finding of rare side effects has resulted in regulatory attention and legal action.
As the legal procedure advances, affected individuals and their families demand fair compensation and recognition of vaccine-related injuries.
